Avanos Medical, Inc.
AVNS
$11.44
-$0.14-1.21%
NYSE
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 1.60% | 4.48% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1.60% | 4.48% | |||
| Cost of Revenue | 10.74% | 6.69% | |||
| Gross Profit | -6.62% | 2.56% | |||
| SG&A Expenses | -7.54% | 10.30% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 666.67% | 118.75% | |||
| Total Operating Expenses | 2.78% | 9.73% | |||
| Operating Income | -80.00% | -75.73% | |||
| Income Before Tax | 98.42% | -882.47% | |||
| Income Tax Expenses | -77.78% | -70.97% | |||
| Earnings from Continuing Operations | 98.18% | -1,263.64% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 98.18% | -1,263.64% | |||
| EBIT | -80.00% | -75.73% | |||
| EBITDA | -20.80% | -37.19% | |||
| EPS Basic | 98.18% | -1,258.31% | |||
| Normalized Basic EPS | -172.97% | -88.75% | |||
| EPS Diluted | 98.18% | -1,285.71% | |||
| Normalized Diluted EPS | -172.97% | -88.57% | |||
| Average Basic Shares Outstanding | 0.22% | 0.43% | |||
| Average Diluted Shares Outstanding | 0.22% | -1.07% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||